Effect of Beta Asarone–The Active Principle of Acorus Calamus in Neuroprotection and Nerve Cell Regeneration on the Pyramidal Region of Hippocampus in Mesial Temporal Lobe Epileptic Rat Models
DOI:
https://doi.org/10.37591/rrjon.v5i1.986Abstract
Epilepsy is a common chronic neurological disorder with seizures. About 1% of people worldwide (65 million) have epilepsy and nearly 80% of cases occur in developing countries [1]. MTLE is the major form of focal epilepsy associated with hippocampal atrophy or sclerosis. For this study we produced a model of mesial temporal epilepsy sterotaxically by inducing kainic acid into the right hippocampus. For this study animals were divided into seven groups CO, LC-2, AC35-2, BA20-2, LC-7, AC35-7 and BA20-7, all the animals except CO group were undergone the lesion surgery. The groups AC35 and BA20 were given ethanolic extract of acorus calamus 35 mg/kg body weight and beta asarone 20 mg/kg body weight accordingly. After lesion surgery the lesion control animals exhibited epileptic seizure but the drug group animals have not shown any epileptiform activity. Histological studies were done on both 2nd and 7th day to find out the neuro protective and neuro regenerative ability of the drug employed and they proved the neuro protective and regenerative ability of both the drugs but with an add on effect with beta asarone.
Keywords: AC=Calamus oil, BA=Beta Asarone, CO=Control, LC=Lesion control, LD 50=Lethal dose 50, IP=Intraperitoneal, MTLE=Mesial Temporal Lobe Epilepsy
Cite this Article
Venkatramaniah C, Mary Antony Praba A. Effect of Beta Asarone–The Active Principle of Acorus Calamus in Neuroprotection and Nerve Cell Regeneration on the Pyramidal Region of Hippocampus in Mesial Temporal Lobe Epileptic Rat Models. Research and Reviews: Journal of Neuroscience (RRJoNS). 2015; 5(1): 19–24p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |